Research output per year
Research output per year
Unit profile
Description
The Division of Translational Cancer Research (TCR) was founded 2013 in conjunction with the formation of Lund University Cancer Center (LUCC) at Medicon Village. TCR consists of nine research groups with different areas of expertise, but together working on projects with the common goal of improving cancer diagnostics and cancer therapy. Our multidisciplinary experimental settings include human genetics, mouse genetics, human tissue platform, stem cell biology and advanced maging, aiming at creating novel diagnostic tools and therapeutic modalities. We believe that the impact of ongoing projects at TCR will open up new horizons and opportunities for individualized treatment of cancer patients, which includes diagnostic tests for matching the right drug to the right patient.
Subject classification (UKÄ)
- Cancer and Oncology
- Cell and Molecular Biology
- Basic Cancer Research
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Collaborations the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Units
Profiles
-
Kristina Aaltonen
- Molecular Pediatric Oncology - Associate researcher
- Division of Translational Cancer Research - Associate professor
- LUCC: Lund University Cancer Centre - Principal investigator
Person
-
Aleksandra Adamska
- Molecular Pediatric Oncology - Postdoctoral fellow
- Division of Translational Cancer Research - Postdoctoral fellow
- LUCC: Lund University Cancer Centre - Postdoc
Person
-
Mattias Aine
- Breast/lungcancer - Associate researcher
- LUCC: Lund University Cancer Centre - Researcher
- Division of Molecular Hematology (DMH) - Postdoctoral fellow
- Research Group Lung Cancer - Research project participant
- Breast/lung cancer - Associate researcher
Person
-
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Gezelius, E., Planck, M., Hazem, B., Nagpal, S. & Wakelee, H., 2025 Dec, In: Cancer Chemotherapy and Pharmacology. 95, 1, 6.Research output: Contribution to journal › Article › peer-review
Open Access -
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
Veerla, S., Martin de la Fuente, L., Li, M., Tang, G., Ebbesson, A., D'Incalci, M., Marchini, S., Mannarino, L., Måsbäck, A., Malander, S., Kannisto, P. & Hedenfalk, I., 2025 May 23.Research output: Contribution to conference › Poster › peer-review
-
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
Taş, İ., Jacobs, R., Albrecht, J., Barrientos, S. A., Åberg, J., Sime, W., Brunnström, H., Persson, H., Kazi, J. U. & Massoumi, R., 2025 Apr 24, In: Journal of Experimental and Clinical Cancer Research. 44, 19 p., 128.Research output: Contribution to journal › Article › peer-review
Open Access
-
Adaptmet: Deconstructing adaptive evolution of metastasis
Pietras, K. (PI)
European Commission - Horizon Europe
2025/03/01 → 2029/02/28
Project: Research
-
Investigating Downstream Molecular Pathways of FLT3 in Acute Myeloid Leukemia: Unraveling Molecular Mechanisms and Therapeutic Potentials
Rönnstrand, L. (Researcher)
2025/01/01 → 2026/12/31
Project: Research
-
Definition of supporting and inhibiting cell types which contribute to the development of brain tumors in children
Pietras, K. (PI)
The Swedish Childhood Cancer Fund
2025/01/01 → 2027/12/31
Project: Research
Infrastructure
-
In vivo Imaging System Spectrum CT 3D
Massoumi, R. (Manager)
Division of Translational Cancer ResearchInfrastructure
Activities
-
Engineering Health Crossroads workshop: EH-DDH & LUCC-Breast
Sandberg, F. (Organiser), Saal, L. (Organiser), Alkner, S. (Organiser), Bernhardsson, B. (Participant), Sandsten, M. (Participant), Stridh, M. (Participant), Nilsson, M. (Participant), Fontes, M. (Participant), Ehinger, A. (Participant), Förnvik, D. (Participant), Saghir, H. (Participant), Saini, H. (Participant), Dalene Skarping, I. (Participant), Jessica, P. (Participant), Bocci, M. (Participant), Morsing, M. (Participant), Meng, P. (Participant), de Marchi, T. (Participant) & Dahlblom, V. (Participant)
2023 Oct 19Activity: Participating in or organising an event › Organisation of workshop/ seminar/ course
-
Vetenskapligt kvällsmöte med fokus på HER2-positiv samt trippelnegativ bröstcancer
Ehinger, A. (Invited speaker), Loman, N. (Invited speaker), Killander, F. (Invited speaker) & Staaf, J. (Invited speaker)
2023 Sept 6Activity: Participating in or organising an event › Participation in workshop/ seminar/ course
-
4th Swedish Tumor Microenvironment retreat
Pantaleo, J. (Organiser)
2022 Nov 28 → 2022 Nov 30Activity: Participating in or organising an event › Organisation of conference
Prizes and distinction
-
SCRM 2025 Best Poster Award
Veerla, S. (Recipient), 2025 May 23
Prize: Prize (including medals and awards)
-
-
Consolidator grant from the Swedish Research Council (VR COG)
Bexell, D. (Recipient), 2023
Prize: Prize (including medals and awards)